{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:52:33Z","timestamp":1791827553946,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10072-026-09236-5","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:25:34Z","timestamp":1787628334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined antithrombotic therapy vs. oral anticoagulation alone for ischemic stroke with concomitant atrial fibrillation and large artery atherosclerosis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2679-2232","authenticated-orcid":false,"given":"Samuel","family":"Oliveira de Amorim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1931-015X","authenticated-orcid":false,"given":"Matheus","family":"da Silva Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4476-2357","authenticated-orcid":false,"given":"Cid","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6483-7991","authenticated-orcid":false,"given":"Felipe Henrique Lima","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1409-9542","authenticated-orcid":false,"given":"Nathan Fellipe Cardoso da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4898-3601","authenticated-orcid":false,"given":"Leonardo","family":"Reischoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1607-9976","authenticated-orcid":false,"given":"Jos\u00e9 Alexandre","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1854-4970","authenticated-orcid":false,"given":"Alex","family":"Alqudah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonata Ribeiro","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9700-9938","authenticated-orcid":false,"given":"Marcos Manoel","family":"Honorato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"9236_CR1","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ahj.2008.06.029","volume":"156","author":"S Goto","year":"2008","unstructured":"Goto S, Bhatt DL, R\u00f6ther J, Alberts M, Hill MD, Ikeda Y et al (2008) Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J 156:855\u2013863e2. https:\/\/doi.org\/10.1016\/j.ahj.2008.06.029","journal-title":"Am Heart J"},{"key":"9236_CR2","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCULATIONAHA.110.009035","volume":"123","author":"RR Huxley","year":"2011","unstructured":"Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ et al (2011) Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 123:1501\u20131508. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.009035","journal-title":"Circulation"},{"key":"9236_CR3","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1161\/STROKEAHA.120.032232","volume":"52","author":"J-H Park","year":"2021","unstructured":"Park J-H, Chung J-W, Bang OY, Kim G-M, Choi K-H, Park M-S et al (2021) Atherosclerotic Burden and Vascular Risk in Stroke Patients With Atrial Fibrillation. Stroke Am Heart Association 52:1662\u20131672. https:\/\/doi.org\/10.1161\/STROKEAHA.120.032232","journal-title":"Stroke Am Heart Association"},{"key":"9236_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0002-9343(99)00415-5","volume":"108","author":"L Frost","year":"2000","unstructured":"Frost L, Engholm G, Johnsen S, M\u00f8ller H, Husted S (2000) Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation. Am J Med 108:36\u201340. https:\/\/doi.org\/10.1016\/S0002-9343(99)00415-5","journal-title":"Am J Med"},{"key":"9236_CR5","doi-asserted-by":"publisher","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D et al (2021) Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association. Stroke [Internet]. 2021 [cited 2026 Jan 4];52. https:\/\/doi.org\/10.1161\/STR.0000000000000375","DOI":"10.1161\/STR.0000000000000375"},{"key":"9236_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/2396987319841187","volume":"4","author":"CJ Klijn","year":"2019","unstructured":"Klijn CJ, Paciaroni M, Berge E, Korompoki E, K\u00f5rv J, Lal A et al (2019) Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline. Eur Stroke J 4:198\u2013223. https:\/\/doi.org\/10.1177\/2396987319841187","journal-title":"Eur Stroke J"},{"key":"9236_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/23969873221100032","author":"J Dawson","year":"2022","unstructured":"Dawson J, B\u00e9jot Y, Christensen LM, De Marchis GM, Dichgans M, Hagberg G et al (2022) European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack. Eur Stroke J [Internet]. [cited 2026 Jan 4];7 https:\/\/doi.org\/10.1177\/23969873221100032","journal-title":"Eur Stroke J [Internet]"},{"key":"9236_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.blre.2011.01.007","volume":"25","author":"JS Paikin","year":"2011","unstructured":"Paikin JS, Wright DS, Eikelboom JW (2011) Effectiveness and safety of combined antiplatelet and anticoagulant therapy: A critical review of the evidence from randomized controlled trials. Blood Rev 25:123\u2013129. https:\/\/doi.org\/10.1016\/j.blre.2011.01.007","journal-title":"Blood Rev"},{"key":"9236_CR9","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1016\/j.jacc.2014.02.549","volume":"63","author":"EM Hylek","year":"2014","unstructured":"Hylek EM, Held C, Alexander JH, Lopes RD, De Caterina R, Wojdyla DM et al (2014) Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin. J Am Coll Cardiol 63:2141\u20132147. https:\/\/doi.org\/10.1016\/j.jacc.2014.02.549","journal-title":"J Am Coll Cardiol"},{"key":"9236_CR10","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1177\/23969873231183211","volume":"8","author":"RAF Investigators","year":"2023","unstructured":"Investigators RAF, Caliandro P, Cancelloni V, Marco M, Reale G, Zauli A et al (2023) Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy. Eur Stroke J 8:722\u2013730. https:\/\/doi.org\/10.1177\/23969873231183211","journal-title":"Eur Stroke J"},{"key":"9236_CR11","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1177\/17474930231158211","volume":"18","author":"TJ Kim","year":"2023","unstructured":"Kim TJ, Lee JS, Yoon JS, Oh MS, Kim J-W, Park S-H et al (2023) Optimal use of antithrombotic agents in ischemic stroke with atrial fibrillation and large artery atherosclerosis. Int J Stroke 18:812\u2013820. https:\/\/doi.org\/10.1177\/17474930231158211","journal-title":"Int J Stroke"},{"key":"9236_CR12","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1007\/s12975-020-00822-z","volume":"11","author":"J-T Kim","year":"2020","unstructured":"Kim J-T, Lee JS, Kim BJ, Park J-M, Kang K, Lee SJ et al (2020) Effectiveness of Adding Antiplatelets to Oral Anticoagulants in Patients with Acute Ischemic Stroke with Atrial Fibrillation and Concomitant Large Artery Steno-Occlusion. Transl Stroke Res 11:1322\u20131331. https:\/\/doi.org\/10.1007\/s12975-020-00822-z","journal-title":"Transl Stroke Res"},{"key":"9236_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41598-023-51013-3","volume":"14","author":"J Heo","year":"2024","unstructured":"Heo J, Lee H, Lee IH, Lim IH, Hong S-H, Shin J et al (2024) Combined use of anticoagulant and antiplatelet on outcome after stroke in patients with nonvalvular atrial fibrillation and systemic atherosclerosis. Sci Rep 14:304. https:\/\/doi.org\/10.1038\/s41598-023-51013-3","journal-title":"Sci Rep"},{"key":"9236_CR14","doi-asserted-by":"publisher","first-page":"104899","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104899","volume":"29","author":"K Nii","year":"2020","unstructured":"Nii K, Takemura Y, Inoue R, Morinaga Y, Mitsutake T, Higashi T (2020) Safety of direct oral anticoagulant - and antiplatelet therapy in patients with atrial fibrillation treated by carotid artery stenting. J Stroke Cerebrovasc Dis 29:104899. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104899","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"9236_CR15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3174\/ajnr.A7482","volume":"43","author":"B Pardo-Galiana","year":"2022","unstructured":"Pardo-Galiana B, Medina-Rodriguez M, Millan-Vazquez M, Cabezas-Rodriguez JA, Lebrato-Hernandez L, Ainz-Gomez L et al (2022) Antithrombotic Treatment after Carotid Stenting in Patients with Concomitant Atrial Fibrillation. Am J Neuroradiol 43:727\u2013730. https:\/\/doi.org\/10.3174\/ajnr.A7482","journal-title":"Am J Neuroradiol"},{"key":"9236_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11883-019-0808-4","volume":"21","author":"Z Wang","year":"2019","unstructured":"Wang Z, Korantzopoulos P, Liu T (2019) Carotid Atherosclerosis in Patients with Atrial Fibrillation. Curr Atheroscler Rep 21:55. https:\/\/doi.org\/10.1007\/s11883-019-0808-4","journal-title":"Curr Atheroscler Rep"},{"key":"9236_CR17","doi-asserted-by":"publisher","first-page":"e000858","DOI":"10.1136\/bmjgh-2018-000858","volume":"4","author":"JPT Higgins","year":"2019","unstructured":"Higgins JPT, L\u00f3pez-L\u00f3pez JA, Becker BJ, Davies SR, Dawson S, Grimshaw JM et al (2019) Synthesising quantitative evidence in systematic reviews of complex health interventions. BMJ Glob Health 4:e000858. https:\/\/doi.org\/10.1136\/bmjgh-2018-000858","journal-title":"BMJ Glob Health"},{"key":"9236_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/bmj.n71. n71","journal-title":"BMJ"},{"key":"9236_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5:210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"9236_CR20","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928\u2013d5928. https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"9236_CR21","doi-asserted-by":"publisher","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ i4919. https:\/\/doi.org\/10.1136\/bmj.i4919","DOI":"10.1136\/bmj.i4919"},{"key":"9236_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT (2021) Risk-of\u2010bias VISualization (robvis): An R package and Shiny web app for visualizing risk\u2010of\u2010bias assessments. Res Synth Methods 12:55\u201361. https:\/\/doi.org\/10.1002\/jrsm.1411","journal-title":"Res Synth Methods"},{"key":"9236_CR23","unstructured":"Project R (2025) What is R? [Internet]. [cited 2025 Jan 5]. https:\/\/www.r-project.org\/about.html. Accessed 5 Jan"},{"key":"9236_CR24","doi-asserted-by":"publisher","unstructured":"Schwarzer G Meta: general package for meta-analysis [Internet]. 2006 [cited 2026 Jan 5]. p 8.2-1. https:\/\/doi.org\/10.32614\/CRAN.package.meta","DOI":"10.32614\/CRAN.package.meta"},{"key":"9236_CR25","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1001\/jamaneurol.2025.3662","volume":"82","author":"S Okazaki","year":"2025","unstructured":"Okazaki S, Tanaka K, Yazawa Y, Doijiri R, Koga M, Ihara M et al (2025) Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis: A Randomized Clinical Trial. JAMA Neurol 82:1227. https:\/\/doi.org\/10.1001\/jamaneurol.2025.3662","journal-title":"JAMA Neurol"},{"key":"9236_CR26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s10557-023-07433-4","volume":"38","author":"SL Harrison","year":"2024","unstructured":"Harrison SL, Buckley BJR, Lane DA, Fazio-Eynullayeva E, Underhill P, Hill A et al (2024) Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke. Cardiovasc Drugs Ther 38:731\u2013737. https:\/\/doi.org\/10.1007\/s10557-023-07433-4","journal-title":"Cardiovasc Drugs Ther"},{"key":"9236_CR27","doi-asserted-by":"publisher","first-page":"123352","DOI":"10.1016\/j.jns.2024.123352","volume":"468","author":"GA Mohamed","year":"2025","unstructured":"Mohamed GA, Qdais AA, Hanna M, Myesrlis EP, Zulfiqar M, Turan TN (2025) Antithrombotic therapy for secondary Stroke prevention in patients with symptomatic large artery atherosclerosis and atrial fibrillation (FIB-CAS study) A single-center experience. J Neurol Sci 468:123352. https:\/\/doi.org\/10.1016\/j.jns.2024.123352","journal-title":"J Neurol Sci"},{"key":"9236_CR28","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1056\/NEJMoa2407362","volume":"391","author":"MS Cho","year":"2024","unstructured":"Cho MS, Kang D-Y, Ahn J-M, Yun S-C, Oh Y-S, Lee CH et al (2024) Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease. N Engl J Med 391:2075\u20132086. https:\/\/doi.org\/10.1056\/NEJMoa2407362","journal-title":"N Engl J Med"},{"key":"9236_CR29","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","volume":"381","author":"S Yasuda","year":"2019","unstructured":"Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M et al (2019) Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. N Engl J Med 381:1103\u20131113. https:\/\/doi.org\/10.1056\/NEJMoa1904143","journal-title":"N Engl J Med"},{"key":"9236_CR30","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2303048","volume":"388","author":"U Fischer","year":"2023","unstructured":"Fischer U, Koga M, Strbian D, Branca M, Abend S, Trelle S et al (2023) Early versus Later Anticoagulation for Stroke with Atrial Fibrillation. N Engl J Med 388:2411\u20132421. https:\/\/doi.org\/10.1056\/NEJMoa2303048","journal-title":"N Engl J Med"},{"key":"9236_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C et al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 42:373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"9236_CR32","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","volume":"23","author":"J Steffel","year":"2021","unstructured":"Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG et al (2021) 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. EP Eur 23:1612\u20131676. https:\/\/doi.org\/10.1093\/europace\/euab065","journal-title":"EP Eur"},{"key":"9236_CR33","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/CIRCULATIONAHA.118.036768","volume":"139","author":"Y Matsumura-Nakano","year":"2019","unstructured":"Matsumura-Nakano Y, Shizuta S, Komasa A, Morimoto T, Masuda H, Shiomi H et al (2019) Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation: OAC-ALONE Study. Circulation 139:604\u2013616. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036768","journal-title":"Circulation"},{"key":"9236_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/2396987319838100","volume":"4","author":"P Amarenco","year":"2019","unstructured":"Amarenco P, Kim JS, Labreuche J, Giroud M, Lee B-C, Mahagne M-H et al (2019) Treat stroke to target trial design: First trial comparing two LDL targets in patients with atherothrombotic strokes. Eur Stroke J 4:271\u2013280. https:\/\/doi.org\/10.1177\/2396987319838100","journal-title":"Eur Stroke J"},{"key":"9236_CR35","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1080\/13696998.2020.1837502","volume":"23","author":"GJ Fermann","year":"2020","unstructured":"Fermann GJ, Lovelace B, Christoph MJ, Lingohr-Smith M, Lin J, Deitelzweig SB (2020) Major bleed costs of atrial fibrillation patients treated with factor Xa inhibitor anticoagulants. J Med Econ 23:1409\u20131417. https:\/\/doi.org\/10.1080\/13696998.2020.1837502","journal-title":"J Med Econ"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09236-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09236-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09236-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:34:29Z","timestamp":1791826469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09236-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["9236"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09236-5","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work is a secondary synthesis of already-published studies and does not involve the collection of original human data, biological material, or animal experiments. According to journal ethical standards and COPE guidance, ethical approval was not required.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No identifiable patient images or case-based individual information are included in this manuscript.","order":2,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This meta-analysis did not involve the recruitment of human participants or the use of individual-level identifiable data.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no financial or non-financial competing interests related to the content of this meta-analysis.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work has not been presented at any scientific meeting.","order":5,"name":"Ethics","label":"Conference presentation","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This systematic review and meta-analysis is based exclusively on data extracted from previously published studies. All information included in this manuscript is presented in aggregated form, and no unpublished figures, tables, images, or copyrighted material have been directly reproduced from the original sources. All included studies are properly cited according to journal standards.","order":6,"name":"Ethics","label":"Permission to reproduce material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was registered in PROSPERO (registration number: CRD420261309490).","order":7,"name":"Ethics","label":"Protocol registration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that this manuscript is an honest, accurate, and transparent account of the study being reported, and that no important aspects have been omitted.","order":8,"name":"Ethics","label":"Transparency declaration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":9,"name":"Ethics","label":"Clinical trial registration","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"735"}}